As of December 31, 2025, Tikun Olam-Cannbit Pharmaceuticals Ltd. has 1,699.29 shares outstanding.
| Shares Outstanding | 1,699.29 |
As of December 31, 2025, Tikun Olam-Cannbit Pharmaceuticals Ltd. maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.06 |
| Debt / Equity | -56.21 |
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 11.50 |
As of December 31, 2025, Tikun Olam-Cannbit Pharmaceuticals Ltd. holds 3.00M in cash and equivalents against 1.18B in total debt, resulting in a net debt position of 1.14B. Total book value stands at -1.32B, with working capital of -1.95B providing operational flexibility.
| Cash & Cash Equivalents | 3.00M |
| Total Debt | 1.18B |
| Net Debt | 1.14B |
| Equity (Book Value) | -1.32B |
| Book Value Per Share | -774,853.03 |
| Working Capital | -1.95B |
Tikun Olam-Cannbit Pharmaceuticals Ltd.'s most recent stock split took place on August 24, 2026 with a 500:1 split ratio.
| Last Split Date | 8/24/2026 |
| Split Ratio | 500:1 |
Already premium?